Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
Newbury Pharmaceuticals AB banner
N

Newbury Pharmaceuticals AB
STO:NEWBRY

Watchlist Manager
Newbury Pharmaceuticals AB
STO:NEWBRY
Watchlist
Price: 1.17 SEK -2.5% Market Closed
Market Cap: kr35.6m
Write Note Create Alert Ask AI

Newbury Pharmaceuticals AB
Investor Relations

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company, which engages in specialty prescription drugs inn the Scandinavian markets. The company is headquartered in Lund, Skane. The company went IPO on 2022-02-04. The Company’s existing portfolio is focused on the Scandinavian market and consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology.

Show more
Loading
NEWBRY
OMX Stockholm 30
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Karl Alexius Tiger Karlsson
Founder & Executive Chairman
No Bio Available
Mr. Christoffer Tell
Chief Financial Officer
No Bio Available
Mr. Fredrik Hellqvist
Vice President of Sales & Marketing
No Bio Available
Mr. Lars Minor
Chief Executive Officer
No Bio Available

Contacts

Address
SKANE
Lund
Medicon Village, Scheeletorget 1
Contacts
+4646121120
www.newburypharma.com
sparklesyt

See Also

Summary
NEWBRY intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEWBRY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEWBRY stock valuation using valuation multiples.
Wall Street Estimates
NEWBRY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEWBRY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 329,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett